Union of v3-substanceAdminSubstitution and v3-substanceAdminSubstitution

This is the CodeSystem that contains all the codes in Substance Admin Substitution (http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution) and Substance Admin Substitution (http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution). E.g. what you have to deal with if you get resources containing codes in either of them

Generated Narrative: CodeSystem 0229f20e-bdf6-4558-8625-5d09cf27fb48-3566

Properties

This code system defines the following properties for its concepts

Name

Code

URI

Type

Description

Specializes

Coding

The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.

Generalizes

Coding

Inverse of Specializes. Only included as a derived relationship.

internalId

http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id

code

The internal identifier for the concept in the HL7 Access database repository.

Not Selectable

notSelectable

http://hl7.org/fhir/concept-properties#notSelectable

boolean

Indicates that the code is abstract - only intended to be used as a selector for other concepts

Status

status

http://hl7.org/fhir/concept-properties#status

code

Designation of a concept's state. Normally is not populated unless the state is retired.

Specializes

Coding

Generalizes

Coding

Inverse of Specializes. Only included as a derived relationship.

internalId

http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id

code

The internal identifier for the concept in the HL7 Access database repository.

Not Selectable

notSelectable

http://hl7.org/fhir/concept-properties#notSelectable

boolean

Indicates that the code is abstract - only intended to be used as a selector for other concepts

Status

status

http://hl7.org/fhir/concept-properties#status

code

Designation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This code system http://hl7.org/fhir/comparison/CodeSystem/0229f20e-bdf6-4558-8625-5d09cf27fb48-3566 defines codes in an undefined hierarchy, but no codes are represented here

Lvl	Code	Display	Definition	internalId	Not Selectable	Status	internalId	Not Selectable	Status
1	_ActSubstanceAdminSubstitutionCode	ActSubstanceAdminSubstitutionCode	Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.	21284, 21284	true, true	active, active	21284, 21284	true, true	active, active
2	E	equivalent	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.	23107		active	23107		active
3	EC	equivalent composition	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril	23108		active	23108		active
4	BC	brand composition	Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven	23109		active	23109		active
4	G	generic composition	Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)	16623		active	16623		active
3	TE	therapeutic alternative	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet	16624		active	16624		active
4	TB	therapeutic brand	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet	23105		active	23105		active
4	TG	therapeutic generic	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine	23106		active	23106		active
2	F	formulary	This substitution was performed or is permitted based on formulary guidelines.	16625		active	16625		active
2	N	none	No substitution occurred or is permitted.	16622		active	16622		active
2	E	equivalent	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.	23107, 23107		active, active	23107, 23107		active, active
3	EC	equivalent composition	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril	23108		active	23108		active
4	BC	brand composition	Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven	23109		active	23109		active
4	G	generic composition	Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)	16623		active	16623		active
3	TE	therapeutic alternative	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet	16624		active	16624		active
4	TB	therapeutic brand	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet	23105		active	23105		active
4	TG	therapeutic generic	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine	23106		active	23106		active
3	EC	equivalent composition	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril	23108, 23108		active, active	23108, 23108		active, active
4	BC	brand composition	Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven	23109		active	23109		active
4	G	generic composition	Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)	16623		active	16623		active
4	BC	brand composition	Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven	23109, 23109		active, active	23109, 23109		active, active
4	G	generic composition	Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)	16623, 16623		active, active	16623, 16623		active, active
3	TE	therapeutic alternative	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet	16624, 16624		active, active	16624, 16624		active, active
4	TB	therapeutic brand	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet	23105		active	23105		active
4	TG	therapeutic generic	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine	23106		active	23106		active
4	TB	therapeutic brand	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet	23105, 23105		active, active	23105, 23105		active, active
4	TG	therapeutic generic	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine	23106, 23106		active, active	23106, 23106		active, active
2	F	formulary	This substitution was performed or is permitted based on formulary guidelines.	16625, 16625		active, active	16625, 16625		active, active
2	N	none	No substitution occurred or is permitted.	16622, 16622		active, active	16622, 16622		active, active

Union of http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution and http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution

CodeSystem